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Defective neutrophils in patients with chronic granu-
lomatous disease (CGD) cause susceptibility to
extracellular and intracellular infections. Microbes
must first be ejected from intracellular niches to
expose them to neutrophil attack, so we hypothe-
sized that inflammasomes detect certain CGDpatho-
gens upstream of neutrophil killing. Here, we identi-
fied one such ubiquitous environmental bacterium,
Chromobacterium violaceum, whose extreme viru-
lencewas fully counteractedby theNLRC4 inflamma-
some. Caspase-1 protected via two parallel path-
ways that eliminated intracellular replication niches.
Pyroptosis was the primary bacterial clearance
mechanism in the spleen, but both pyroptosis and
interleukin-18 (IL-18)-driven natural killer (NK) cell re-
sponses were required for liver defense. NK cells
cleared hepatocyte replication niches via perforin-
dependent cytotoxicity, whereas interferon-g was
not required. These insights suggested a therapeutic
approach: exogenous IL-18 restoredperforin-depen-
dent cytotoxicity during infection by the inflamma-
some-evasive bacterium Listeria monocytogenes.
Therefore, inflammasomes can trigger complemen-
tary programmed cell death mechanisms, directing
sterilizing immunity against intracellular bacterial
pathogens.
INTRODUCTION
Inflammasomes are innate immune sensors that detect cytosolic
contaminations or perturbations. Whereas canonical inflamma-
somes activate caspase-1, the noncanonical inflammasome
pathway activates caspase-11. Caspase-1 processes inter-
leukin-1b (IL-1b) and IL-18, leading to their secretion, and alsoItriggers a form of programmed lytic cell death known as pyrop-
tosis. The NLRC4 inflammasome responds to bacterial type III
and IV secretion systems (T3SS and T4SS) by specifically de-
tecting three conserved bacterial proteins when they are aber-
rantly translocated into the cytosol of host cells: flagellin, T3SS
rod, and T3SS needle (von Moltke et al., 2013). Like most inflam-
masomes, NLRC4 must signal though the adaptor protein
ASC to promote IL-1b and IL-18 secretion. However, unlike the
PYD-containing inflammasomes (including NLRP3, AIM2, and
pyrin), it can also mediate pyroptosis directly via CARD-CARD
domain interactions with caspase-1 (von Moltke et al., 2013).
Inflammasome-deficient mice are more susceptible to a
variety of pathogens, yet the defense conferred is typically only
incremental. This was perhaps first and most thoroughly
described for Salmonella Typhimurium, which replicates some-
what faster in inflammasome-deficient mice. The overall effect
on the infection is that inflammasome-competent mice die
2 days later than inflammasome-deficient mice (Lara-Tejero
et al., 2006; Raupach et al., 2006). Normalization of death ki-
netics can be accomplished by only a 4-fold change in the infec-
tious dose (Aachoui et al., 2013a; vonMoltke et al., 2013). Similar
or lesser phenotypes are observed with Listeria monocytogenes,
Yersinia pseudotuberculosis, Y. pestis, Francisella novicida,
Mycobacterium tuberculosis, Klebsiella pneumoniae, influenza,
and Candida albicans (Allen et al., 2009; Fernandes-Alnemri
et al., 2010; Gross et al., 2009; Jones et al., 2012; LaRock and
Cookson, 2012; Lightfield et al., 2011; Mayer-Barber et al.,
2010; von Moltke et al., 2013; Sauer et al., 2011; Thomas
et al., 2009; Tsuji et al., 2004; Willingham et al., 2009). This has
led to the conclusion that inflammasomes merely slow the infec-
tious process, allowing the host to survive until an adaptive im-
mune response clears the infection.
Indeed, inflammasomes are ineffective in defense against sys-
temic S. Typhimurium and L. monocytogenes because these
bacteria evade NLRC4, in part by repressing flagellin expression
(Lara-Tejero et al., 2006; von Moltke et al., 2013; Raupach et al.,
2006). We previously engineered S. Typhimurium to express
flagellin during systemic infection and found that it is completely
attenuated in wild-type (WT) mice but remains fully virulent in in-
flammasome-deficient mice. We showed that pyroptosis ejectsmmunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc. 987
bacteria from intracellular replication niches, exposing them to
attack by neutrophils, which kill the bacteria via reactive oxygen
species (ROSs) (Miao et al., 2010a). The extreme efficiency by
which the innate immune system eradicates evasion-deficient
bacteria starkly contrasts with the typical role for inflamma-
somes in vivo as mechanisms to slow, but not halt, WT bacterial
replication. We therefore hypothesized that there were naturally
occurring environmental microbes that were analogous to engi-
neered evasion-deficient bacteria. Such microbes would almost
never cause disease in immune-competent individuals because
inflammasome detection results in completely penetrant innate
immunity.
Although caspase-1-deficient patients have not yet been
identified, ROS-deficient patients are well studied. Chronic gran-
ulomatous disease (CGD) is caused by a variety of germline
mutations in the genes for NADPH oxidase 2 (NOX2, encoded
by Phox) that greatly reduce or eliminate ROS production in
phagocytes (Holland, 2013). Patients with CGD are susceptible
to infection by a characteristic array of not only extracellular,
but also intracellular, pathogens (Marciano et al., 2015). In order
for neutrophils to attack intracellular bacteria, these microbes
must first be ejected from their intracellular niche. Thus, we
hypothesized that a subset of CGD-associated pathogens are
detected by inflammasomes and released from intracellular
niches via pyroptosis. Herein we identified one such bacterium,
C. violaceum, and used it to reveal unappreciated inflamma-
some-driven tissue-specific clearance mechanisms.
RESULTS
Inflammasomes Prevent Lethal Infection by Specific
CGD Pathogens
We performed a survey of five CGD-specific bacteria in inflam-
masome-deficient mice. These were selected based on their
inability to infect immunocompetent humans, and the bacterial
species are further described in the Supplemental Experimental
Procedures.
Burkholderia thailandensis is a ubiquitous soil bacterium that
uses a T3SS to invade the cytosol, where it is detected by cas-
pase-11 (Aachoui et al., 2013a). Consistent with the hypothesis
that caspase-11-dependent pyroptosis exposes intracellular
bacteria to killing by neutrophils, mice with the most common
form of autosomal-recessive CGD (Ncf1–/–, which encodes
p47phox) were also susceptible to B. thailandensis infection,
surviving slightly longer than Casp1–/–Casp11–/– mice while WT
mice were fully resistant (Figures 1A and 1B). In contrast, species
within the related Burkholderia cepacia complex (B. cepacia,
B. cenocepacia, B. multivorans) that do not encode the T3SS
were efficiently cleared by WT and Casp1–/–Casp11–/– mice,
but were highly virulent in Ncf1–/– mice (Figures 1C and S1A–
S1D). A similar result was observed for the CGD-tropic patho-
gens Francisella philomiragia (Friis-Møller et al., 2004; Mailman
and Schmidt, 2005) and Serratia marcescens (Lee and Lau,
2013; Marciano et al., 2015) (Figures 1D and S1C–S1F), illus-
trating that inflammasomes were not strictly required for defense
against all CGD-tropic pathogens.
Chromobacterium violaceum is a Gram-negative bacterium
that derives its name from the purple pigment that it produces,
called violacin (Dura´n et al., 2010). C. violaceum is a ubiquitous988 Immunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc.environmental organism that inhabits aquatic environments in
the tropics and subtropics (Lima-Bittencourt et al., 2011). It
encodes two T3SSs, Cpi-1 and Cpi-2, with similarity to the
S. Typhimurium SPI-1 and SPI-2 T3SS, respectively (Brito
et al., 2004; Miki et al., 2010). Although the natural host that
C. violaceum infects is unknown, the Cpi-1 needle and rod pro-
teins can be detected by the mammalian NLRC4 inflammasome
in vitro (Yang et al., 2013; Zhao et al., 2011). Most instances of
C. violaceum infection in humans occur in immune-compro-
mised individuals, with 8.5% of cases occurring in confirmed
CGD patients (Yang and Li, 2011). C. violaceum infection in
CGD patients is typified by rapid bacteremia often without a
nidus of infection, and a 53% mortality rate (Yang and Li,
2011). This is experimentally demonstrated in mice, where
C. violaceum has minimal virulence for WT C57BL/6 mice but
is highly virulent in Ncf1–/– mice (Figure 1E; Segal et al., 2003).
We found that like Ncf1–/– mice, Casp1–/–Casp11–/– mice were
acutely susceptible to C. violaceum infection. As few as 100
CFUs were lethal to Casp1–/–Casp11–/– mice, whereas WT
mice survived a challenge of 1,000,000 CFUs (Figure 1E). This
susceptibility was mirrored by high bacterial burdens in both
the liver and spleen in comparison to WT mice, which cleared
the infection (Figures 1F–1I and S1G–S1J). The exquisite sensi-
tivity of Casp1–/–Casp11–/– mice to C. violaceum represents the
strongest effect of inflammasomes in defense against pathogens
in the published literature, equaled only by their susceptibility to
B. thailandensis (Aachoui et al., 2015).
C. violaceum is liver-tropic in CGD patients (Yang and Li,
2011). Upon examination of mice 3 days after infection with
100 CFUs ofC. violaceum, we observed numerous macroscopic
lesions on the livers of Casp1–/–Casp11–/– mice (Figure S1K),
associated with extensive neutrophil infiltration and a complete
loss of structure around lesion foci in the liver (Figure 1J). These
results revealed that certain environmental microbes, such as
C. violaceum and B. thailandensis, had significant virulence
potential that could not be contained in the absence of a coordi-
nated action between inflammasomes and phagocyte-specific
NADPH oxidase.
NLRC4 Is Required for Protection against Infection by
C. violaceum In Vivo
The T3SS of C. violaceum can be detected by NLRC4 in vitro
(Zhao et al., 2011), but the role of NLRC4 during in vivo infection
of C. violaceum has not been examined. Therefore, we next set
out to determine whether the canonical inflammasome pathway
(activating caspase-1) or the noncanonical inflammasome
pathway (caspase-11) was more important for defense against
C. violaceum. We found that caspase-11 was dispensable for
defense, whereas Nlrc4–/–Asc–/– mice (which lack all canonical
inflammasomes except NLRP1a/1b) remained highly suscepti-
ble to infection (Figure 2A). ASC is completely required for
signaling by the PYD-containing inflammasomes and for the
cytokine outputs from NLRC4 (Wen et al., 2013). However,
ASC is dispensable for NLRC4-driven pyroptosis (Miao et al.,
2010a). Whereas ASC-deficient mice had an intermediate sus-
ceptibility, NLRC4 was absolutely required for resistance to
infection (Figures 2B–2F and S2A). These results suggest a
role for pyroptosis and IL-1b and/or IL-18 in defense against
C. violaceum.
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Figure 1. Inflammasomes and the NADPH Oxidase Are Required to Clear Specific CGD Pathogens
(A–D) Mice were infected i.p. with (A) 2 3 107 or (B) 1 3 104 CFU of B. thailandensis, (C) 1 3 106 CFU of B. cepcacia, (D) or 1 3 106 CFU of F. philomiragia and
monitored for survival. Casp1–/–Casp11–/– mice referred to as Casp1-11DKO. Mice: (A) WT = 9, Casp1-11DKO = 10, Ncf1–/– = 10; (B) WT = 4, Casp1-11DKO = 6,
Ncf1–/– = 9; (C) n = 4 for all; (D) n = 5 for all.
(E) Mice were infected i.p. with C. violaceum (Cv) at the indicated doses and monitored for survival. Mice: WT = 4, Casp1-11DKO = 7, Ncf1–/– = 4.
(F–I) Mice were infected i.p. with 100 CFUs of Cv and bacterial burdens were measured in the liver (F and H) and spleen (G and I) 72 hr later (F and G) or 17 hr later
(H and I).
(J) Mice were infected i.p. with 100 CFUs of Cv and 72 hr later livers and spleens were embedded in paraffin and H&E stained.
Data and statistical analyses are representative of at least two experiments (A–D, H–I), three experiments (F–G), or pooled from two experiments (E). Dashed line
indicates limit of detection. *p% 0.05; survival curve analysis (A–E), two-tailed unpaired t test (F–I). See also Figure S1.Differential Role for Pyroptosis against C. violaceum in
the Spleen and Liver
We next compared caspase-deficient mice to Il1b–/–Il18–/– mice
to better understand the contributions of pyroptosis and cyto-
kine secretion. Similar to the Asc–/– mice, Il1b–/–Il18–/– mice
had an intermediate phenotype (Figures 3A and 3B), again
consistent with roles for both pyroptosis and cytokines. Interest-
ingly, we observed a different phenotype in the spleen, where
Il1b–/–Il18–/– mice had few or no bacteria, like WT mice, whereas
Casp1–/–Casp11–/– mice carried significant burdens (Figure 3C).IThis suggested that pyroptosis was the primary effector mecha-
nism in the spleen but that a more complex defense mechanism
existed in the liver.
IL-18 Is Protective in the Liver whereas IL-1b Is
Dispensable
IL-1b and IL-18 are pleiotropic cytokines that promote innate
and adaptive immune responses. IL-1b is well known to induce
fever and to potentiate local inflammatory responses, resulting
in neutrophil influx (Dinarello, 2010). IL-18 was first describedmmunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc. 989
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Figure 2. Canonical Inflammasome
Signaling via NLRC4 Prevents Lethal Infec-
tion by C. violaceum In Vivo
(A and B) Mice were infected i.p. with 100 CFUs of
Cv and monitored for survival. Nlrc4–/–Asc–/– mice
referred to as Nlrc4-AscDKO. Mice: (A) Casp1-
11DKO = 4,Nlrc4-AscDKO = 4,Casp11–/– = 5; (B) n =
4 for all.
(C–F) Mice were infected i.p. with 100 CFUs of Cv,
and bacterial burdens were measured in livers
(C and E) and spleens (D and F) 72 hr later.
All data and statistical analyses are representative
of at least three experiments. *p % 0.05; survival
curve analysis (A and B); two-tailed unpaired t test
(C–F). See also Figure S2.as an interferon-g (IFN-g)-stimulating cytokine, and IFN-g re-
sponses are well established to promote defense against intra-
cellular pathogens (Souza-Fonseca-Guimaraes et al., 2012). In
order to study the role of these cytokines in a more penetrant
survival challenge, we increased the infectious dose to 104
CFUs, resulting in uniform lethality in Il1b–/–Il18–/– mice. At this
dose, Il18–/– and Asc–/– mice were also highly susceptible to
infection, whereas Il1b–/– mice were fully resistant (Figure 3D).
In support of this, Asc–/–, Il18–/–, and Il1b–/–Il18–/– mice all had
elevated bacterial burdens in the liver, but not spleen, in com-
parison to WT and Il1b–/– mice (Figures 3E, 3F, S3A, and S3B).
These results further supported our hypothesis that pyroptosis
was the primary defense mechanism against C. violaceum in
the spleen and revealed that IL-18, but not IL-1b, was protective
in the liver.
Natural Killer Cell Cytotoxicity Is Required to Clear
Intracellular Replication Niches
In considering IL-18-responsive cell types, we found that NK
cells have higher IL-18R expression than any other cell type or
organ (Figure S4A). Accordingly, depletion of NK and NKT cells
from WT mice resulted in elevated bacterial burden in the liver
but not the spleen (Figures 4A and 4B). Because IL-18 secretion
drives IFN-g production in natural killer (NK) cells and certain
T cells (Chaix et al., 2008) and because IFN-g is well established
as a potent cytokine in defense against intracellular pathogens
(Adib-Conquy et al., 2014; Le-Barillec et al., 2005; Souza-Fon-
seca-Guimaraes et al., 2012), we hypothesized that IFN-gwould
be the primary effector mechanism downstream of IL-18. Sur-
prisingly, this was not the case, as shown by the fact that
Ifng–/– mice had bacterial burdens comparable to those seen in
WT mice (Figures 4C and 4D).990 Immunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc.We then considered whether the
predominance of IL-18 for liver but not
splenic defense was in part due to the
differences in cell populations between
the liver and spleen. The spleen is primar-
ily composed of macrophages, T cells,
B cells, and dendritic cells. In contrast,
80%–90% of the liver is composed of he-
patocytes, with the remainder composed
of Kupffer cells (liver-resident macro-
phages), NK cells, and other immune cells(Gre´goire et al., 2007). Thus, when considering target cells that
C. violaceum can infect, the liver is dramatically different from
the spleen. Interestingly, primary hepatocytes did not express
detectableamountsofcaspase-1afterLPSstimulation (Figure4E).
In contrast, splenocytes expressed abundant caspase-1 (Fig-
ure 4E), as do liver mononuclear cells (Petrasek et al., 2012). This
might explain why pyroptosis appears to be sufficient to defend
the spleen, but not the liver. Indeed, hepatocytes contained 90%
of the C. violaceum bacterial burden in the liver (Figure 4F), and
C. violaceum also efficiently infected primary hepatocytes in vitro
(Figure 4G). However, consistent with the lack of caspase-1
expression, we did not observe appreciable lytic cell death in in-
fected primary hepatocytes (Figures 4H and S4D). In contrast,
rapid and robust caspase-1/11-dependent lytic cell death was
observed in liver immune cells and splenocytes (Figure 4H).
Consequently, we hypothesized that a cell death pathway parallel
to pyroptosis was required to eject the bacteria from their replica-
tive niche in hepatocytes and expose them to neutrophil killing.
Previous studies show that exposure to IL-18 can prime the
cytotoxic effects of NK and NKT cells in addition to promoting
IFN-g production (Dao et al., 1998; Son et al., 2001). These cyto-
toxic effects require perforin, a pore-forming protein that NK/
NKT and cytotoxic T lymphocytes (CTLs) use to kill target cells
(Ka¨gi et al., 1994; Lopez et al., 2013). However, although NK
and/or NKT cell cytotoxic activity is a well-established antiviral
effector mechanism (Shabani et al., 2014), it has not been estab-
lished as an important defense mechanism against intracellular
bacteria. For example, WT and Prf1–/– mice had similar bacterial
burdens after infection with the model intracellular pathogens
L. monocytogenes or S. Typhimurium (Figures 4I, 4J, S4B, and
S4C). However, interpretation of these results were confounded
by the fact that both L. monocytogenes and S. Typhimurium
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Figure 3. Differential Role for Pyroptosis in
the Liver and Spleen
(A and B) Mice were infected with 100 CFUs (A) or
104 CFUs (B) Cv and monitored for survival.
Il1b–/–Il18–/– mice referred to as Il1b-Il18DKO.
Mice: (A) Casp1-11DKO = 5, Il1b-Il18DKO = 7,
Il1b–/– = 5; (B) Il1b-Il18DKO = 5, Il1b–/– = 5, Il18–/– =
4, Asc–/– = 5.
(C–F) Mice were infected i.p. with 100 CFUs of Cv
and bacterial burdens were measured in livers
(C and E) and spleens (D and F) 72 hr later.
Data and statistical analyses are representative of
at least two experiments (A and D–F) or three ex-
periments (B and C) or pooled from two experi-
ments (E and F). *p% 0.05; survival curve analysis
(A and D), two-tailed unpaired t test (B, C, E, F).
Asterisk over a line indicates that all datasets un-
der the line have p % 0.05 for each pair-wise
comparison possible. See also Figure S3.largely evade NLRC4 in vivo (Miao et al., 2010a; Sauer et al.,
2011), thereby minimizing IL-18 secretion. Nevertheless, we
examined whether perforin has a role in defense against
C. violaceum, which was readily detected by NLRC4 in vivo.
Both Prf1–/– andCasp1–/–Casp11–/–mice had significantly higher
bacterial burdens thanWT and Ifng–/–mice in the liver, but again,
only Casp1–/–Casp11–/– mice had substantial bacterial burdens
in the spleen (Figures 4K, 4L, S4E, and S4F). These results indi-
cated that NK and/or NKT cells were protective in the liver but
were dispensable for splenic clearance (where pyroptosis was
sufficient) and suggested that their cytotoxic activity was the pri-
mary protective mechanism.
The Adaptive Immune System Is Dispensable for
Defense against C. violaceum
Several cell types express perforin, including NK cells, NKT cells,
and CTLs (Ka¨gi et al., 1994; Lopez et al., 2013). To determine
whether NKT cells and/or CTLs were required for resistance to
C. violaceum, we examined Rag1–/– mice, which lack all B and
T cells. Interestingly, Rag1–/– and WT mice had similar bacterial
burdens and clearance kinetics (Figures 5A and 5B), demon-
strating that neither NKT cells nor CTLs were the primary cyto-
toxic effector cells against C. violaceum infection. Additionally,
we concluded that inflammasomes provided innate immunity
against this ubiquitous environmental microbe that did not
require an adaptive immune response.
IL-18 Administration Improves NK Cell Recruitment and
Cytotoxicity In Vivo
We hypothesized that a lack of IL-18 in inflammasome-deficient
mice prevented appropriate recruitment and/or stimulation of
NK cells, so we examined whether administration of exogenousImmunity 43, 987–997, NIL-18 could restore NK cell function. IL-18
therapy resulted in significantly reduced
bacterial burdens in Casp1–/–Casp11–/–
and Il1b–/–Il18–/– mice (Figures 6A and
6B). However, because exogenous IL-
18 did not fully normalize bacterial bur-
dens in Il1b–/–Il18–/– mice, it was likely
that IL-18 therapy could be further opti-mized from a pharmacologic standpoint. To examine the
response of NK cells to IL-18, we performed flow cytometry on
liver immune cells isolated from untreated and IL-18-treated
Nlrc4–/–Asc–/– mice. IL-18 therapy promoted a 3-fold increase
in conventional NK cell numbers, but no increase of liver-resident
NK cell and NK1.1+CD3+ cell (likely NKT cell) numbers (Figures
6C, 6D, and S5A). Granzyme B is a serine protease that is
secreted from NK cells and CTLs along with perforin to mediate
target cell death and is an established marker for cyotolytic acti-
vation of these cell types. Notably, we saw increased granzyme
Bmean fluorescence intensity (MFI) in conventional NK cells, but
no significant increase in theMFI of liver-resident NK or NKT cells
(Figures 6E and S5B). These results were consistent with the lack
of phenotype in Rag1–/– mice (Figure 5) and suggested that IL-18
was driving both NK cell recruitment to infected target organs
and increased activation.
Our model thus far suggested that pyroptosis was the primary
defense mechanism in the spleen, whereas IL-18 drove defense
in the liver. Thus, the observation that IL-18 treatment was
therapeutic in the spleen of Casp1–/–Casp11–/– mice was unex-
pected (Figure 6B). However, Casp1–/–Casp11–/– mice are defi-
cient for both pyroptosis and IL-18 in the spleen, so pyroptosis
and NK cytotoxicity could be independently sufficient to prevent
bacterial colonization in the spleen. Unfortunately, pyroptosis-
deficient mice have not been developed, so we cannot directly
assess whether endogenous IL-18 would be sufficient in the
absence of pyroptosis.
We next sought to provide evidence that IL-18 therapy acts
through NK cells. Consistent with our findings, Nlrc4–/–Asc–/–
mice were highly susceptible to C. violaceum infection, and
bacterial clearance could be rescued by IL-18 therapy (Fig-
ure 6F). However, when simultaneously depleted of NK cells,ovember 17, 2015 ª2015 Elsevier Inc. 991
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Figure 4. Cytotoxic Activity of NK Cells Is
Required for Clearance of C. violaceum
(A–D, K, and L) Mice were infected i.p. with 104
CFUs (A, B, K, and L) or 100 CFUs (C and D) Cv at
the indicated doses and bacterial burdens were
measured in livers (A, C, and K) and spleens (B, D,
and L) 72 hr later.
(A and B) Mice were injected i.p. with 75 mg of
isotype or anti-NK1.1 antibody at 1 and 3 days
prior to infection.
(E) Primary hepatocytes and splenocytes from
naive WT mice were treated with LPS, lysed, and
examined for caspase-1 via immunoblot.
(F) Mice were infected i.p. with 100CFUs of Cv and
bacterial burdens were measured in livers 72 hr
later. Equal weight liver sections were removed
and the hepatocyte fraction was graphed as a
percentage of the total burden by weight.
(G) Primary hepatocytes were infected with Cv at
an MOI of 25 and percentage of invasive bacteria
was determined via gentamycin protection assay.
(H) Primary hepatocytes, liver immune cells, and
splenocytes were infected with Cv at an MOI of 10
and treated with gentamycin, and LDH release
was determined (note, different splenocytes have
a distinct LDH content per cell, thus in this case
LDH release does not directly translate to percent
lysis).
(I and J) Mice were infected i.p. with 103 CFUs
of L. monocytogenes (Lm) and bacterial burdens
were measured in livers (I) and spleens (J) 72 hr
later.
Data and statistical analyses are representative
of two experiments (C, D, I, J) or pooled from two
(K, L) or three (A, B) experiments. *p% 0.05; two-
tailed unpaired t test (A–D and I–L). Error bars in
(F)–(H) indicate SEM. See also Figure S4.IL-18 therapy failed. Further, IL-18 therapy also required cyto-
toxic activity, asPrf1–/–mice failed to respond (Figure 6G). There-
fore, IL-18 acted upstream of NK cell cytotoxic activity against
intracellular bacterial infection in vivo.
Inorder todemonstrate thatC.violaceum-infectedhepatocytes
can be killed by NK cells, we combined ex vivo and in vitro tech-
niques. Hepatocytes were isolated from C. violaceum-infected
Ncf1–/– mice, which carried huge bacterial burdens in their liver.
These were used as target cells for lysis by liver immune cells
harvested from infectedWTmice (Figure 6H).Weobserved hepa-
tocyte killing that was ablated by NK cell depletion. Furthermore,
hepatocyte killing increased with cells from IL-18-treated mice
(Figure 6H). In summation, NK cells killed hepatocytes in vitro,
and this killing was enhanced with IL-18 therapy, consistent
with our in vivo results (Figure 6).
Exogenous IL-18 Is Therapeutic against
L. monocytogenes
Our observations revealed a unique link between inflamma-
somes and NK cell cytotoxicity in defense against a ubiquitous992 Immunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc.intracellular environmental bacterium, so
we sought to discover whether thismech-
anism was applicable to a bona fide
human pathogen. Like C. violaceum,L. monocytogenes is well established to infect hepatocytes
(Cousens and Wing, 2000). However, unlike C. violaceum,
L. monocytogenes evades inflammasome detection. Therefore,
we examined the efficacy of IL-18 treatment during
L. monocytogenes infection. Bacterial burdens were significantly
decreased in the liver and spleen of IL-18-treated WT mice
(Figures 7A and 7B), but there was no difference between un-
treated and treated Prf1–/– mice in the liver (Figure 7A). Splenic
burdens were decreased in Prf1–/– mice upon IL-18 therapy
(Figure 7B), suggesting that there were also perforin-indepen-
dent mechanisms of clearing the spleen, perhaps through
IFN-g. Importantly, despite the increased susceptibility of
Ifng–/– mice to L. monocytogenes infection, IL-18 therapy was
still beneficial to these mice (Figures 7C and 7D). Moreover,
IL-18 therapy was still effective in Rag–/– mice, indicating that
IL-18 acted independently of the adaptive immune system, as
it did during C. violaceum infection (Figures 7E and 7F). Thus,
perforin-dependent cytotoxicity against intracellular bacteria
was a bona fide defense mechanism downstream of IL-18
secretion that was underappreciated due to the ability of many
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Figure 5. Adaptive Immune Responses Are Not Required for Steril-
izing Immunity against C. violaceum
Mice were infected i.p. with 103 CFUs of Cv and bacterial burdens were
measured in livers (A) and spleens (B) at the indicated times. Data and
statistical analyses are representative of two experiments. *p % 0.05; two-
tailed unpaired t test.bacteria, such as L. monocytogenes, to evade inflammasome
detection in vivo.
DISCUSSION
Although inflammasomes are appreciated to be an innate im-
mune mechanism that slows the course of infection, prevailing
published evidence indicates that inflammasomes ultimately
fail to eradicate pathogens. However, studies using bacteria en-
gineered to remove inflammasome evasion hint at the converse
hypothesis: that inflammasomes have the unrealized capacity of
directing sterilizing immunity (Miao et al., 2010a, 2010b; Sauer
et al., 2011). We propose that the importance of inflammasomes
during infection is underappreciated because phenotypes have
been interpreted in the face of confounding pathogenic evasion
strategies. We further propose that animals are constantly
exposed to a milieu of highly virulent environmental microbes
that have remained uncharacterized because inflammasomes
completely prevent disease in immunocompetent individuals. It
is important to note that under our model, inflammasomes would
be unimportant against environmental microbes that do not
encode such potent virulence traits.
Concordantly, C. violaceum and B. thailandensis are ubiqui-
tous water and soil bacteria that rarely cause infection in hu-
mans, despite the fact that they encode potent virulence traits,
including T3SSs that enable intracellular replication or cytosolic
invasion (Wiersinga et al., 2006; Yang and Li, 2011). Our results
herein show that inflammasomes detect these virulence traits
and initiate a specific innate immune defense program that pro-
vides sterilizing innate immunity. To our knowledge, the role of
inflammasomes in defense against C. violaceum (shown here)
andB. thailandensis (Aachoui et al., 2015) are themost penetrant
inflammasome phenotype against any infection, be it bacterial,
viral, fungal, or parasitic.We hypothesize that this is one example
of a wide array of potentially lethal environmental microbes.IExposure to such microbes might exert a strong evolutionary
pressure that could explain the maintenance and expansion
of inflammasome genes. We propose that if people lacked
NLRC4, swimming in freshwater lakes or streams might carry
an incredible risk of death subsequent to infection by
C. violaceum.
Why should we be interested in studying bacteria to which
almost all people are innately immune? The answer lies in the
fact that these bacteria offer us the opportunity to study the
innate immune system in its fully functional state, unobscured
by pathogenic evasion strategies. Our studies of C. violaceum
reveal the importance of inflammasomes in driving parallel
mechanisms to clear intracellular replication niches. Pyroptosis
appears to be fully competent to protect the spleen, where
inflammasome-expressing macrophages are abundant. This
probably occurs in liver macrophages as well. It should be noted
that we have not provided definitive evidence that pyroptosis is
the mechanism of clearance in the spleen; our data address
four of seven criteria that we have previously described (Aachoui
et al., 2013b). A rapid pyroptotic response in the early hours
of infection is thus predicted to eliminate the bacteria before
they can replicate to high numbers. In addition to pyroptosis,
inflammasome-driven IL-18 primes NK cells to kill infected hepa-
tocytes in the liver, providing an example where NK cell cytotox-
icity is critical to bacterial clearance in vivo.
The two primary effector mechanisms used by NK cells
are production of IFN-g and cytotoxicity. NK cell cytotoxicity, a
well-established mechanism against viral pathogens, is not
established in defense against bacterial pathogens in vivo
(Souza-Fonseca-Guimaraes et al., 2012). There are numerous
studies that demonstrate NK cell cytotoxicity in vitro against
bacterially infected cells (Katz et al., 1990; Souza-Fonseca-Gui-
maraes et al., 2012), yet these responses were later found to be
ineffective during infection in vivo (Junqueira-Kipnis et al., 2003;
Souza-Fonseca-Guimaraes et al., 2012), probably because of
pathogenic evasion strategies. We identified cytotoxicity, instead
of IFN-g, as the NK effector mechanism employed against
C. violaceum-infected hepatocytes in vivo. L. monocytogenes is
also highly tropic for hepatocytes, yet NK cell cytotoxicity fails to
clear this infection (Cousens and Wing, 2000). We propose that
this is due to inflammasome evasion strategies employed by
L. monocytogenes in vivo, whereby IL-18 secretion is limited
(Sauer et al., 2011). Here we used IL-18 therapy as an innate im-
munebooster toharnessNKcytotoxicityandspecificallyeliminate
L. monocytogenes-infected cells in the innate phase of infection.
Therefore, when we study bona fide pathogens, it is difficult
to distinguish between innate immune mechanisms that are
simply not useful from those that are actively evaded. The
latter could be harnessed therapeutically to combat the
infection, and environmental bacteria like C. violaceum and
B. thailandensis might be the key to uncovering such insights.
We used the well-studied susceptibility of CGD patients to
identify extremely virulent bacteria that are normally cleared
by the innate immune system with exquisite efficiency. It is
likely that other environmental microbes, in a similar fashion,
will inform our understanding of previously underappreciated
innate immune-clearance mechanisms. These microbes pro-
vide a lens with which to understand the capabilities of the
innate immune system when it is correctly activated, actingmmunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc. 993
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Figure 6. Exogenous IL-18 Recruits NK Cells and Primes Their Cytotoxic Effects
(A–G) Mice were infected i.p. with 100 CFUs of Cv and bacterial burdens were measured in livers (A, F, and G) and spleens (B) 72 hr later.
(A, B, and F) Mice were injected i.p. with PBS or recombinant mouse IL-18 (0.2 mg/dose at 0, 24, and 48 hr).
(F) Mice were injected i.p. with 75 mg of isotype or anti-NK1.1 antibody at 1 and 3 days prior to infection.
(C–E) Liver immune cells were collected and prepared for flow cytometry 1 day after infection (C). Markers for conventional NK (NK1.1hiDX5+), liver-resident NK
(NK1.1hiDX5–), and (probably) NKT (NK1.1+DX5–CD3+) cell populations (D) were determined in addition to granzyme B staining (E).
(H) Hepatocytes were harvested fromNcf1–/–mice infected with 100 Cv 17 hpi. Liver immune cells were harvested fromWTmice infected with 104 Cv under three
conditions: isotype antibody treatment, anti-NK1.1 antibody treatment, or IL-18 therapy. Cells were coincubated in a 96-well plate and hepatocyte killing was
determined by LDH assay 6 hr later. A model of the experimental setup is provided.
Data and statistical analyses are representative of at least two experiments (A–F) or pooled from two experiments (F). *p% 0.05; two-tailed unpaired t test (A, B,
and D–H). Error bars in (D), (E), and (H) indicate SEM. See also Figure S5.
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Figure 7. L. monocytogenes Burdens Are Reduced upon IL-18 Administration
Mice were infected i.p. with 103 CFUs of Lm and injected i.p. with PBS or recombinant mouse IL-18 (24, 48, and 72 hr), and bacterial burdens were measured in
WT and Prf1/mice (A and B), Ifng/mice (C and D), and Rag1/mice (E and F) livers (A, C, and E) and spleens (B, D, and F) 4 days later. Data and statistical
analyses are pooled from two experiments. *p% 0.05; two-tailed unpaired t test.as powerful tools to help develop therapeutics that bypass the
evasion strategies of bona fide pathogens.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
The following strains were used in this work: C. violaceum (ATCC 12472),
S. Typhimurium (CS401), L. monocytogenes (10403s; kind gift from Daniel A.
Portnoy), and B. thailandensis (passaged through Casp1–/–Casp11–/–
mouse strain). Additionally, the following strains were isolated from CGD
patients: B. cepacia, B. multivorans, B. cenocepacia, F. philomiragia, and
S. marcescens.
S. Typhimurium and all Burkholderia species were grown in Luria-Bertani
medium (LB). C. violaceum, S. marcescens, and L. monocytogenes were
grown in brain heart infusion (BHI). F. philomiragia was grown in BHI + iso-
vitalex. All strains were grown overnight at 37C and back-diluted (1:40)
for 2 hr in their respective media for use in both in vitro and in vivo
experiments.
Mouse Infections
Mouse strain information and housing conditions are described in the Supple-
mental Experimental Procedures. For all mouse infections, 8- to 12-week-old
mice were infected with the designated colony forming units (CFUs) of log
phase bacteria in PBS by intraperitoneal (i.p.) injection. Livers and spleens
were harvested at the indicated time point (3, 4, 10, or 21 days after infection)
and homogenized and dilutions plated on LB or BHI as described above. For
NK cell depletion, mice were injected i.p. with 75 mg anti-NK1.1 PK136 or
isotype control C1.18.4 (BioXCell) at 3 and 1 dpi. Depletion of NK1.1-pos-
itive cells was confirmed by flow cytometry. For IL-18 therapies, mice were in-
jected i.p. with 0.2 mg recombinant mouse IL-18 (rmIL-18; MBL) at the time
of infection, 24, and 48 hpi (C. violaceum infections) or 24, 48, and 72 hpi
(L. monocytogenes infections).
Histology
Livers and spleenswere fixed in formalin and embedded in paraffin to generate
section of 5 mm thickness. Paraffin sections were counterstained with hemo-
toxylin and eosin.
Cell Isolation
A detailed protocol is in the Supplemental Experimental Procedures. In brief,
livers were extracted, perfused with Collagenase D, mashed through a cell
strainer (Falcon), and washed with DMEM. Cells were spun and the superna-Itant removed. Pellets were resuspended in 44% Percoll (GE Healthcare) in
DMEM and underlaid with 66% Percoll. Cells were spun at 2,000 3 g and
the hepatocytes were harvested from the upper layer. Lymphocytes were
treated with RBC lysis buffer and spun, the supernatant removed, and the pel-
let resuspended in DMEM or 13 PBS depending on usage. Splenocytes were
harvested in the same manner but without the Percoll gradient. Average hepa-
tocyte purity as assessed by CD45 staining was determined to be 99.5%.
Average liver immune cell purity as assessed visually by hemacytometer
counting was determined to be >99.5%.
Immunoblots
For immunoblots, total protein from lysates of 53 104 hepatocytes or spleno-
cytes was analyzed. Caspase-1 expression was determined using an anti-cas-
pase-1 antibody (clone 4B4, Genentech). Blots were stripped and equivalent
loading of protein was ensured by immunoblot using anti-b-actin HRP anti-
body (AbCam, Cat# ab20272, RRID: AB_445482) diluted 1:20,000.
Bacterial Count Enumeration
For percentages of intracellular C. violaceum in vivo, equal weights of livers
were harvested. Total CFUs were obtained from one section, CFU specific
to the hepatocyte fraction from the second section via the cell isolation tech-
nique, and the hepatocyte CFU graphed as a percentage of the total. For per-
centages of intracellular C. violaceum in vitro, hepatocytes were isolated,
seeded in a 96-well plate, and allowed to rest for 2 hr.C. violaceumwere grown
to log phase and hepatocytes were infected at an MOI of 25, with gentamicin
(5 ng/ml) added 30 min p.i. At 1, 2, 3, and 4 hr after infection, intracellular bac-
terial burden was determined by plating cell lysates on BHI.
Flow Cytometry
For flow preparation, cells were Fc-blocked with anti-CD16/CD32 and stained
with anti-CD45-PercPCy5.5 (104), NK1.1-FITC (PK136) (BD Biosciences, Cat#
551114, RRID: AB_394052), CD3, Granzyme B, and the cell viability marker
Aqua dead live-AmCyan, all from BD. Cells were fixed in 2% PFA and samples
were analyzed on a Becton Dickinson LRSIII (HTS) (UNC Flow Cytometry Core
Facility).
Assessment of NK Killing In Vitro
Hepatocytes were harvested from Ncf1–/– mice 17 hpi with 100 Cv. Liver im-
mune cells were harvested from WT mice under three conditions at 48 hpi.
(1 and 2) WT mice were treated with isotype or anti-NK1.1 antibody days 1
and 3 prior to infection with 104 Cv. (3) WT mice were infected with 104 Cv
and treated with 0.2 mg rm IL-18 at the time of infection and 24 hr later.mmunity 43, 987–997, November 17, 2015 ª2015 Elsevier Inc. 995
Hepatocytes and immune cells were seeded into 96-well plates and allowed
to rest for 2 hr. Non-adherent immune cells were used to enrich for NK
cells. The hepatocytes and immune cells were then coincubated at an effec-
tor:target ratio (E:T) of 50:1 and cell death was evaluated 6 hr later. LDH release
was defined as (LDHEXPERIMENTAL – LDHEFFECTORS – LDHSPONTANEOUS)/
(LDHMAXIMAL – LDHSPONTANEOUS), where LDHEFFECTOR refers to the liver im-
mune cells, LDHSPONTANEOUS refers to hepatocytes, and LDHMAXIMAL refers
to total lysis of hepatocytes by Triton X-100.
Statistics
Error bars represent the standard deviation of technical replicates. A standard
two-tailed unpaired t test (GraphPad Prism 5, RRID: rid_000081) was used for
statistical analysis, wherein p values of%0.05 were considered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2015.10.010.
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